Norges Bank’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-364,902
| Closed | -$24.7M | – | 2121 |
|
|
2019
Q3 | $24.7M | Buy |
364,902
+40,890
| +13% | +$2.81M | 0.01% | 1355 |
|
|
2019
Q2 | $18.8M | Sell |
324,012
-17,714
| -5% | -$1.05M | 0.01% | 1541 |
|
|
2019
Q1 | $23.9M | Buy |
341,726
+16,072
| +5% | +$1.19M | 0.01% | 1377 |
|
|
2018
Q4 | $21M | Buy |
325,654
+12,820
| +4% | +$899K | 0.01% | 1369 |
|
|
2018
Q3 | $22M | Hold |
312,834
| – | – | 0.01% | 1469 |
|
|
2018
Q2 | $15.8M | Buy |
312,834
+21,200
| +7% | +$841K | 0.01% | 1639 |
|
|
2018
Q1 | $9.13M | Buy |
291,634
+4,100
| +1% | +$136K | ﹤0.01% | 1769 |
|
|
2017
Q4 | $9.83M | Hold |
287,534
| – | – | ﹤0.01% | 1744 |
|
|
2017
Q3 | $9.23M | Buy |
287,534
+57,294
| +25% | +$1.81M | ﹤0.01% | 1759 |
|
|
2017
Q2 | $7.49M | Buy |
230,240
+75,572
| +49% | +$2.39M | ﹤0.01% | 1820 |
|
|
2017
Q1 | $4.87M | Hold |
154,668
| – | – | ﹤0.01% | 1885 |
|
|
2016
Q4 | $4.55M | Hold |
154,668
| – | – | ﹤0.01% | 1884 |
|
|
2016
Q3 | $4.27M | Buy |
154,668
+70,576
| +84% | +$1.97M | ﹤0.01% | 1896 |
|
|
2016
Q2 | $2.18M | Hold |
84,092
| – | – | ﹤0.01% | 1995 |
|
|
2016
Q1 | $2.08M | Sell |
84,092
-21,100
| -20% | -$579K | ﹤0.01% | 1988 |
|
|
2015
Q4 | $3.7M | Sell |
105,192
-34,435
| -25% | -$922K | ﹤0.01% | 1928 |
|
|
2015
Q3 | $2.96M | Sell |
139,627
-38,643
| -22% | -$996K | ﹤0.01% | 1979 |
|
|
2015
Q2 | $4.95M | Hold |
178,270
| – | – | ﹤0.01% | 1897 |
|
|
2015
Q1 | $5.45M | Sell |
178,270
-20,284
| -10% | -$645K | ﹤0.01% | 1878 |
|
|
2014
Q4 | $6.35M | Sell |
198,554
-3,175
| -2% | -$103K | ﹤0.01% | 1838 |
|
|
2014
Q3 | $5.71M | Sell |
201,729
-201,729
| -50% | -$5.62M | ﹤0.01% | 1872 |
|
|
2014
Q2 | $11.1M | Buy |
403,458
+201,729
| +100% | +$5.37M | ﹤0.01% | 1910 |
|
|
2014
Q1 | $5.31M | Hold |
201,729
| – | – | ﹤0.01% | 1871 |
|
|
2013
Q4 | $5.91M | Hold |
201,729
| – | – | ﹤0.01% | 1839 |
|
|
2013
Q3 | $6.17M | Hold |
201,729
| – | – | ﹤0.01% | 1814 |
|
|
2013
Q2 | $6.4M | Buy |
+201,729
| New | +$6.63M | ﹤0.01% | 1724 |
|
Norges Bank's GHDX Position: Q4 2019 in Review
Norges Bank sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 364,902 shares — an estimated $24.7M sold.
Norges Bank first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $24.7M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Norges Bank reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Norges Bank sold 364,902 Genomic Health, Inc. shares in Q4 2019, an estimated $24.7M.
- Norges Bank first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
- Norges Bank's Genomic Health, Inc. position peaked at $24.7M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Norges Bank's 13F filing for Q4 2019, filed 12 Feb 2020.